Direct Meds vs SkinnyRx
Direct Meds has an open FDA warning letter dated September 9, 2025. SkinnyRx has an open FDA warning letter dated February 20, 2026. No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Direct Meds / SkinnyRx
Direct Meds
7.1/10
SkinnyRx
6.3/10
Both Direct Meds and SkinnyRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (Direct Meds 7.1, SkinnyRx 6.3). How we are paid
What the record shows
- 01
Direct Meds has an open FDA warning letter dated September 9, 2025. SkinnyRx has an open FDA warning letter dated February 20, 2026.
- 02
Neither names the pharmacy that compounds its medication.
- 03
No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price.
- 04
Only SkinnyRx lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.
- 05
Direct Meds covers one state SkinnyRx does not.
- 06
Direct Meds holds you to a 90-day supply shipped at once, remaining months billed every 30 days; SkinnyRx states you can cancel at any time.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Direct Meds
SkinnyRx
$297/mo
$3,564 a year
$99/mo
first month only; not compared
$399/mo
$4,788 a year
$99/mo
first month only; not compared
$249/mo
$2,988 a year
$149/mo
first month only; not compared
$299/mo
$3,588 a year
$199/mo
first month only; not compared
$1,400/mo
$16,800 a year
$1,400/mo
$16,800 a year
$248/mo
$2,976 a year
$248/mo
$2,976 a year
Read off each seller’s own pages. Direct Meds: October 17, 2026. SkinnyRx: October 30, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Direct Meds
7.1/10The record gives Direct Meds no edge on this pair.
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
- Minimum commitment before you can cancel
The case for SkinnyRx
6.3/10- Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Direct Meds does not price
- States you can cancel at any time
- Open FDA warning letter, February 20, 2026
- Names no compounding pharmacy
Scores
Direct Meds 7.1 · SkinnyRx 6.3 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Direct Meds vs SkinnyRx: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Collective9.1
From $59/mo
Visit site - AgelessRx7.4
From $99/mo prepaid
Visit site - Eden8.7
From $99/mo
Visit site
Sellers closest to these two
- Direct Meds vs Henry Meds
- Direct Meds vs Fridays
- Direct Meds vs RxSpan MD
- Direct Meds vs Wellorithm
- SkinnyRx vs Found
- SkinnyRx vs ShedRx
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks